Skip to main content
. 2017 Aug 10;8(4):343–350. doi: 10.5306/wjco.v8.i4.343

Figure 1.

Figure 1

Kaplan-Meier survival curves. Survival time for BC vs CRC (P = 0.042, χ2 test). 1: Survival data of all patients with liver metastases of BC after TACP (n = 19). Median survival time 13.2 mo; 2: Survival data of patients with liver metastases of CRC after TACP (n = 17). Median survival time 9.3 mo. BC: Breast cancer; CRC: Colorectal cancer; TACP: Trans-arterial chemoperfusion.